Be on schedule.Score better.

support@savemydegree.com

EN

Our Services

Get 15% Discount on your First Order

VC Cardiogenic Shock Case Study Questions

Case Study Information:

A 53 y/o African American male with a history of CAD s/p remote PCI to unknown vessel(s), ischemic cardiomyopathy, HTN, DM, and CKD III has been hospitalized with decompensated heart failure. He is a retired salesman by profession. He has a 40 pack year history of smoking; he quit after his MI 6 years ago.

His medications include: Glyburide 10 mg, isosorbide mononitrate 80 mg daily, spironolactone 100 mg daily, digoxin 0.25 mg daily, furosemide 120 mg daily, enalapril 20 mg daily, and ASA 81 mg daily.

Echocardiography demonstrated regional wall motion abnormalities, moderate mitral regurgitation, and an ejection fraction of 25-35%, down from his previous EF of 40-50% on imaging obtained ~6 months ago. The patient was referred for cardiac catheterization.

Repeat coronary angiography appreciated multivessel coronary artery disease not amenable to PCI. An intra-aortic balloon pump was placed and CT surgery was consulted for CABG evaluation.

On transfer from the cath lab table to the stretcher, the patient converted to ventricular fibrillation and experienced cardiopulmonary arrest. ROSC was achieved after 3 minutes of ACLS and the patient was transferred to the CCU intubated and on vasopressor support. As the CCU AGACNP, you physically examine the patient and note that he is pallid, cold to the touch, with diffuse rhonchi on auscultation, and 3 pitting edema to his bilateral lower extremities.

Answer the questions below in 3 pages or less (excluding title page and references), in APA format.

1. Summarize the pathophysiology that is occurring in this patient.

2. Discuss anticipated invasive/non-invasive monitoring strategies for this patient and his expected hemodynamic parameters.

3. Summarize the management of the patient in the above scenario. Discuss the management decision based on evidence from the literature and utilization of current practice guidelines. At least one peer-reviewed, scholarly publication should be discussed, providing statistics from a research study or systematic review/meta-analysis. 

Share This Post

Email
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Reddit

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

Trevino, A. J. (2021). Investigating Social Problems.

Trevino, A. J. (2021). Investigating Social Problems. Available from: VitalSourceBookshelf, (3rd Edition). SAGE Publications, Inc  This is the book Please respond to the following prompt. Grammar and spelling count. Draw upon the textbook and lecture notes in your response. What troubling social condition are you most concerned with (that may

Overview In this module, you learned how to monitor key

Overview In this module, you learned how to monitor key performance indicators (KPIs) and boost revenue-cycle management in healthcare organizations. You also explored how data analytics can be leveraged to maintain a robust revenue cycle. In this assignment, you will determine how KPIs support the strategic planning and financial performance

As a new division manager in a health care organization, you

As a new division manager in a health care organization, you have been given an opportunity to attend a lobbying workshop in Washington, D.C. Before attending the workshop, you must research current health care legislation. In preparation, it is important that you use your influencing skills and demonstrate an understanding of the health care policy

Assignment 1: Understanding the Canadian Healthcare System

Assignment 1: Understanding the Canadian Healthcare System Objective: The primary objective of this assignment is to conduct thorough research on the   structure and components of the Canadian healthcare system. Students are expected to gain   insights into its organization, funding mechanisms, and key challenges and achievements, with a  

Recommend one FDA-approved drug, one off-label drug, and one

Recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating neuro cognitive disorder in pregnant women. Explain the risk assessment you would use to inform your treatment decision  making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the

design a method of communicating age appropriate screening

The purpose of this Assignment is for you to design a method of communicating age appropriate screening guidelines to the appropriate population. This can either be a trifold brochure or a 10 slide PowerPoint presentation. Directions 1. Select a screening test and the age appropriate population at risk. 2. Introduce